Effect of ouabain on metabolic oxidative state in living cardiomyocytes evaluated by time-resolved spectroscopy of endogenous NAD(P)H fluorescence

Journal of Biomedical Optics

Volumn 17, Issue 10, 2012, Pages

  Chorvatova, Alzbeta ^a,b   Elzwiei, Fathia ^b,c   Mateasik, Anton ^a   Chorvat Jr , Dusan ^a  

^a INTERNATIONAL LASER CENTER   (Slovakia)

^b Research Center   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardiac cells; Fluorescence lifetime spectrometry; Mitochondrial oxidative metabolic state; NAD(P)H fluorescence; Ouabain

Indexed keywords

CARDIOTONIC AGENT; LACTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OUABAIN; PYRUVIC ACID;

ANIMAL; ARTICLE; DRUG EFFECT; FEMALE; HEART MUSCLE CELL; METABOLISM; METHODOLOGY; MITOCHONDRION; OXIDATION REDUCTION REACTION; RAT; SPECTROFLUOROMETRY; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOTONIC AGENTS; FEMALE; LACTIC ACID; MITOCHONDRIA; MYOCYTES, CARDIAC; NAD; NADP; OUABAIN; OXIDATION-REDUCTION; PYRUVIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE;

EID: 84872199838     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.17.10.101505     Document Type: Article

References (38)

1. H. Furstenwerth, Ouabain-the insulin of the heart, Int. J. Clin. Pract. 64(12), 1591-1594 (2010).
2. A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova, Endogenous cardiotonic steroids: Physiology, pharmacology, and novel therapeutic targets, Pharmacol. Rev. 61(1), 9-38 (2009).
3. Z. Xie and T. Cai, Na-K-ATPase-mediated signal transduction: From protein interaction to cellular function, Mol. Interv. 3(3), 157-168 (2003).
4. Z. Xie, Molecular mechanisms of NaK-ATPase-mediated signal transduction, Ann. New York Acad. Sci. 986, 497-503 (2003). (Pubitemid 36584154)
5. Z. Xie et al., Intracellular reactive oxygen species mediate the linkage of NaK-ATPase to hypertrophy and its marker genes in cardiac myocytes, J. Biol. Chem. 274(27), 19323-19328 (1999).
6. T. Liu, D. A. Brown, and B. O'Rourke, Role of mitochondrial dysfunction in cardiac glycoside toxicity, J. Mol. Cell. Cardiol. 49(5), 728-736 (2010).
7. D. Chorvat, Jr. et al., Rejection of transplanted hearts in patients evaluated by the component analysis of multi-wavelength NAD(P)H fluorescence lifetime spectroscopy, J. Biophotonics 3(10-11), 646-652 (2010).
8. D. Chorvat, Jr. and A. Chorvatova, Multi-wavelength fluorescence lifetime spectroscopy: A new approach to the study of endogenous fluorescence in living cells and tissues, Laser Phys. Lett. 6(3), 175-193 (2009).
9. D. K. Bird et al., Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH, Cancer Res. 65(19), 8766-8773 (2005). (Pubitemid 41377365)
10. R. Niesner et al., Noniterative biexponential fluorescence lifetime imaging in the investigation of cellular metabolism by means of NAD(P)H autofluorescence, Chemphyschem 5(8), 1141-1149 (2004).
11. V. Bassien-Capsa et al., Structural, functional and metabolic remodeling of rat left ventricular myocytes in normal and in sodiumsupplemented pregnancy, Cardiovasc. Res. 69(2), 423-431 (2006). (Pubitemid 43098798)
12. D. Chorvat, Jr. and A. Chorvatova, Spectrally resolved time-correlated single photon counting: A novel approach for characterization of endogenous fluorescence in isolated cardiac myocytes, Eur. Biophys. 36(1), 73-83 (2006). (Pubitemid 44736054)
13. D. Chorvat, Jr. et al., Spectral unmixing of flavin autofluorescence components in cardiac myocytes, Biophys. J. 89(6), L55-L57 (2005).
14. D. Chorvat, Jr. et al., Application of spectral unmixing in multiwavelengthtime-resolvedspectroscopy,Proc.SPIE6771,677105(2007).
15. B. Chance, Pyridine nucleotide as an indicator of the oxygen requirements for energy-linked functions of mitochondria, Circ. Res. 38(5 Suppl. 1), I31-I38 (1976).
16. D. N. Romashko, E. Marban, and B. O'Rourke, Subcellular metabolic transients and mitochondrial redox waves in heart cells, Proc. Natl. Acad. Sci. USA 95(4), 1618-1623 (1998). (Pubitemid 28103442)
17. B. Chance and J. B. Neilands, Studies on lactic dehydrogenase of heart, II. a compound of lactic dehydrogenase and reduced pyridine nucleotide, J. Biol. Chem. 199(1), 383-387 (1952).
18. D. M. Jameson, V. Thomas, and D. M. Zhou, Time-resolved fluorescence studies on NADH bound to mitochondrial malate dehydrogenase, Biochim. Biophys. Acta 994(2), 187-190 (1989). (Pubitemid 19030823)
19. J. R. Lakowicz et al., Fluorescence lifetime imaging of free and proteinbound NADH, Proc. Natl. Acad. Sci. USA 89(4), 1271-1275 (1992).
20. K. Blinova et al., Distribution of mitochondrial NADH fluorescence lifetimes: Steady-state kinetics of matrix NADH interactions, Biochemistry 44(7), 2585-2594 (2005). (Pubitemid 40279562)
21. H. D. Vishwasrao et al., Conformational dependence of intracellular NADH on metabolic state revealed by associated fluorescence anisotropy, J. Biol. Chem. 280(26), 25119-25126 (2005). (Pubitemid 40934604)
22. K. J. Davies and J. H. Doroshow, Redox cycling of anthracyclines by cardiac mitochondria, I. anthracycline radical formation by NADH dehydrogenase, J. Biol. Chem. 261(7), 3060-3067 (1986). (Pubitemid 17204909)
23. R. S. Balaban and F. W. Heineman, Control of mitochondrial respiration in the heart in vivo, Mol. Cell. Biochem. 89(2), 191-197 (1989). (Pubitemid 19223260)
24. R. Moreno-Sanchez, Regulation of oxidative phosphorylation in mitochondria by external free Ca2+ concentrations, J. Biol. Chem. 260(7), 4028-4034 (1985). (Pubitemid 15096469)
25. V. K. Mootha, A. E. Arai, and R. S. Balaban, Maximum oxidative phosphorylation capacity of the mammalian heart, Am. J. Physiol. 272(2 Pt. 2), H769-H775 (1997).
26. V. Bassien-Capsa et al., Metabolic remodelling of cardiac myocytes during pregnancy: The role of mineralocorticoids, Can. J. Cardiol. 27(6), 834-842 (2011).
27. L. H. Opie and P. Owen, Effects of increased mechanical work by isolated perfused rat heart during production or uptake of ketone bodies. Assessment of mitochondrial oxidized to reduced free nicotinamide-adenine dinucleotide ratios and oxaloacetate concentrations, Biochem. J. 148(3), 403-415 (1975).
28. W. Becker, Advanced Time-Correlated Single Photon Counting Techniques, Springer, New York (2005).
29. D. V. O'Connor and D. Phillips, Time-Correlated Single Photon Counting, Academic Press, London (1984).
30. J. R. Lakowicz, J. R. Principles of Fluorescence Spectroscopy Introducing the Phase-Modulation Methods, Springer, New York (1999).
31. T. Zimmermann, J. Rietdorf, and R. Pepperkok, Spectral imaging and its applications in live cell microscopy, FEBS Lett. 546(1), 87-92 (2003). (Pubitemid 36782286)
32. P. Manunta et al., Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension, Hypertension 34(3), 450-456 (1999). (Pubitemid 29426762)
33. G. A. Beller, J. Conroy, and T. W. Smith, Ischemia-induced alterations in myocardial (NaK)-ATPase and cardiac glycoside binding, J. Clin. Invest. 57(2), 341-350 (1976).
34. P. Pasdois et al., Ouabain protects rat hearts against ischemiareperfusion injury via pathway involving src kinase, mitoKATP, and ROS, Am. J. Physiol. 292(3), H1470-H1478 (2007).
35. D. A. Lopatin et al., Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia, J. Hypertens. 17(8), 1179-1187 (1999). (Pubitemid 29389566)
36. P. A. Hansen et al., Alloxan-induced diabetes reduces sarcolemmal Na-K pump function in rabbit ventricular myocytes, Am. J. Physiol. 292(3), C1070-C1077 (2006).
37. Z. Xie and A. Askari, NaK-ATPase as a signal transducer, Eur. J. Biochem. 269(10), 2434-2439 (2002).
38. G. A. Figtree et al., Reversible oxidative modification: A key mechanism of Na-K pump regulation, Circ. Res. 105(2), 185-193 (2009).